Features Screener Stocks Charts
Sign In Sign Up

Alembic Pharma Income Statement

NSE:APLLTD | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

2-year APLLTD income statement snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Revenue 62.57B 67.15B
Cost of Revenue -17.15B -17.93B
Gross Profit 45.42B 49.21B
Sales, General & Admin -35.80B -38.70B
Operating Income 6.89B 7.72B
Profit Before Tax 6.33B 7.06B
Net Income 6.16B 5.82B
Diluted Shares 196.56M 196.57M
Diluted EPS 31.33 29.68

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹). EPS is earnings per share.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025